Mesothelioma Cancer Centers
The Ohio State University Comprehensive Cancer Center
Doctors Affiliated with this Treatment Facility
The Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) is a National Cancer Institute designated comprehensive cancer center. The center has maintained this designation since 1976. The more than 300 cancer researchers at the center provide individualized care for all cancer patients treated at the OSUCCC – James.
The OSUCCC – James leads the James Cancer Network, enabling patients to receive excellent care across the state of Ohio. Included in the network are the Wooster Community Hospital Health System, Madison County, Clinton Memorial Hospital and St. Rita’s Medical Center. The network elevates the care given across the state. The OSUCCC – James also offers cutting edge pediatric cancer care through the Nationwide Children’s Hospital (NCH).
Mesothelioma care offered at OSUCCC – James uses the most innovative treatment modalities offered across the United States. The physicians at the cancer center use standard therapies, like chemotherapy, radiation and surgery, as well as less accessible and more complicated therapies including monoclonal antibody therapy and other immunotherapies through clinical trials. The center is particularly experienced in treating peritoneal mesothelioma, offering specialized treatments like hyperthermic intraperitoneal chemotherapy (HIPEC).The multidisciplinary teams at OSUCCC – James provide patients with the best care possible to not only treat their cancer but also improve their overall quality of life.
- Clinical trials
- Hyperthermic intraperitoneal chemotherapy (HIPEC)
- Intensity-modulated radiation therapy
- Medical oncology
- Monoclonal antibody therap
- Pleural mesotheliom
- Peritoneal mesothelioma
- Radiation oncology
- Surgical oncology
- Thoracic surgeons
- American College of Surgeons Commission on Cancer (CoC) Accreditation
- Cancer Center ranked as High Performing according to U.S. News & World Report Best Hospitals report
- Foundation for the Accreditation of Cellular Therapy
- Member of the National Comprehensive Cancer Network (NCCN)
- National Cancer Institute (NCI) Designated Comprehensive Cancer Center
- The Joint Commission Accreditation
Mesothelioma Clinical Trials at The Ohio State University Comprehensive Cancer Center
The following clinical trials are in progress or actively recruiting participants at The Ohio State University Comprehensive Cancer Center:
Methoxyamine, Cisplatin, and Pemetrexed Disodium in Treating Patients With Advanced Solid Tumors or Mesothelioma That Cannot Be Removed by Surgery or Mesothelioma That Is Refractory to Pemetrexed Disodium and Cisplatin or Carboplatin
Conditions: Advanced Malignant Solid Neoplasm; Advanced Peritoneal Malignant Mesothelioma; Advanced Pleural Malignant Mesothelioma; Recurrent Peritoneal Malignant Mesothelioma; Recurrent Pleural Malignant Mesothelioma; Refractory Malignant Solid Neoplasm; Unresectable Solid Neoplasm Last Updated: May 6, 2019 Status: Recruiting
Author: Linda Molinari
Editor in Chief, Mesothelioma Cancer AllianceRead about Linda
Reviewer: Annette Charlevois
Patient Support CoordinatorRead about Annette
The Ohio State University Comprehensive Cancer Center. About the OSUCCC – James. Homepage.
The Ohio State University Comprehensive Cancer Center. Cancer Care & Treatment. Cancer Specialties.
The Ohio State University Comprehensive Cancer Center. James Affiliations. About the OSUCCC – James.
The Ohio State University Comprehensive Cancer Center. Peritoneal Mesothelioma Treatment. Peritoneal Mesothelioma.